Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet. - Wikidata - wikimedia - TriplyDB

Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet.

Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet.

http://www.wikidata.org/entity/Q38282979

about

New strategies against drug resistance to herpes simplex virus How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients Mechanism of ganciclovir-induced chain termination revealed by resistant viral polymerase mutants with reduced exonuclease activity Detection of cytomegalovirus drug resistance mutations by next-generation sequencing.The biology of cytomegalovirus drug resistance Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with Cytomegalovirus Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene.Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.Rapid detection of human cytomegalovirus UL97 and UL54 mutations directly from patient samples

P2860

Q26749548-1F015F47-4532-4377-A7BE-26B512E140F5 Q28069489-6E7C314E-0580-4B40-9505-C4B650160310 Q28252113-FBEE0CED-D2C4-491C-AF92-F67642E1BBB5 Q34975934-731F1B2A-4EDB-4306-8CAF-80F9BA20580A Q35684511-6C1E9C38-1371-4C75-A6CE-2316649468E7 Q37242897-3D8085E7-9642-43A3-BFF8-641DB0A25FE5 Q38779846-BD85C923-D64E-4A11-8E41-0964B075564B Q40414645-BEE93375-07F1-4FA2-A7E6-E6DB2BE47B3B Q40728808-D1AC2843-0016-4891-B58A-B8945B28852F Q41430486-C2D64BB5-29A3-43D4-B09C-D3E0D6116C45

P2860

Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet.

http://www.wikidata.org/entity/Q38282979

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Recombinant phenotyping of cyt ...... ther ganciclovir or foscarnet.

@en

type

label

Recombinant phenotyping of cyt ...... ther ganciclovir or foscarnet.

@en

prefLabel

Recombinant phenotyping of cyt ...... ther ganciclovir or foscarnet.

@en

P1433

Q38282979-D6E25530-0150-4C97-9D45-054B2A53A4F0

P1476

Q38282979-2AC23DBB-E12B-4E63-A7DD-A7327901285B

P2093

Q38282979-543D99D3-F002-4E32-86D1-321A1DC8EBD8

Q38282979-99909707-949D-4F25-88DE-9068DEF9BDD2

Q38282979-BE56DB30-DAFA-43F0-8F17-221F0FE1BB61

Q38282979-D7867CE1-0C1E-42C7-B75B-67CF030D1D7E

P2860

Q38282979-00A5ED92-8552-4C40-A7D6-C429DD7766B3

Q38282979-06204B1D-3C9C-404A-8B3F-95AEBA62A877

Q38282979-09083DDA-62A7-4FE8-9A33-4A826CA4FD92

Q38282979-0B84272A-95FC-440E-9FDB-D6777194B3C1

Q38282979-0EDFDBCE-A4FF-4561-B61A-D15651CCC7EE

Q38282979-0F7FC4D2-449B-4A7E-A6E0-86CBBC1F901C

Q38282979-16547190-6796-45F9-BC42-54C138051037

Q38282979-193E979F-6238-49B3-823A-247CA21A4EBC

Q38282979-194C8D8D-E7D5-4D02-88E7-C05B71614E42

Q38282979-249BAD25-AB56-48A4-80DA-BD844DE11EB4

P304

Q38282979-EBC3F9F4-1A8F-4FAD-BC1F-77BD3BD276C8

P31

Q38282979-38BE9BC3-C31F-417A-9632-7725AF27CDB0

P356

Q38282979-55F4F1E1-1959-4BAE-BD98-8D6C677FAD1F

P407

Q38282979-ECDA1C0D-354B-47E2-9ECB-59920440DB5C

P433

Q38282979-5B84B7DE-147C-4A56-A3E6-616C543724A0

P478

Q38282979-DB6266CE-95A0-4363-ADE3-7DC6CF2D03AD

P50

Q38282979-1FB30511-D53D-4C26-BF46-DB443471A777

P577

Q38282979-2D6718D6-AD45-4738-8462-99960D29E0D9

P5875

Q38282979-63ED1505-DCA9-4533-A224-BC7C3225A955

P698

Q38282979-B53CE5EC-5EAC-496E-A0AB-2EA3CC678394

P921

Q38282979-4053CD11-1100-43E9-8DC8-520F0089F956

P932

Q38282979-D5D5CACE-D4B2-4A3A-8774-5696228A81F9

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Recombinant phenotyping of cyt ...... ther ganciclovir or foscarnet.

@en

P2093

Arezki Azzi

http://www.w3.org/2001/XMLSchema#string

Christian Gilbert

http://www.w3.org/2001/XMLSchema#string

Guy Boivin

http://www.w3.org/2001/XMLSchema#string

Nathalie Goyette

http://www.w3.org/2001/XMLSchema#string

P2860

Human cytomegalovirus resistance to antiviral drugs

Optimal description of a protein structure in terms of multiple groups undergoing TLS motion

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells

A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes

Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant

CUPSAT: prediction of protein stability upon point mutations.

Antiviral drug resistance of human cytomegalovirus.

How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients.

Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance.

P304

4019-4027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00334-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Sheng-Xiang Lin

P577

2011-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51253577

http://www.w3.org/2001/XMLSchema#string

P698

21709106

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

3165324

http://www.w3.org/2001/XMLSchema#string